연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
2185. Successful haploidentical transplantation with post-transplant cyclophosphamide for activated phosphoinositide 3-kinase δ syndrome.
Hong CR, Lee S, Hong KT, Choi JY, Shin HY, Choi M, Kang HJ.
J Allergy Clin Immunol Pract.7(3):1034-1037.
Link
2184. Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients.
Chung H, Hong KT, Lee JW, Rhee SJ, Kim S, Yoon SH, Yu KS, Kang HJ.
Bone Marrow Transplant.54(2):284-292.
Link
2183. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer.
Shin YJ1,2, Kim Y1,3, Wen X1,3, Cho NY1,2, Lee S4, Kim WH3, Kang GH5,6.
Clin Epigenetics. 2019 May 14;11(1):77. doi: 10.1186/s13148-019-0661-x.
Link
2182. p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Oh HJ1,2, Bae JM1,2, Wen X2, Jung S2, Kim Y1,2, Kim KJ2, Cho NY2, Kim JH1,2, Han SW3, Kim TY3, Kang GH4,5.
Br J Cancer. 2019 Apr;120(8):797-805. doi: 10.1038/s41416-019-0429-2. Epub 2019 Mar 21.
Link
2181. Prognostic significance of CD103+ immune cells in solid tumor: a systemic review and meta-analysis.
Kim Y1,2, Shin Y1, Kang GH3,4.
Sci Rep. 2019 Mar 7;9(1):3808. doi: 10.1038/s41598-019-40527-4.
Link
2180. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
Kim Y1,2, Lee K2, Jeong S1, Wen X1,2, Cho NY1, Kang GH3,4.
Virchows Arch. 2019 Jul;475(1):49-58. doi: 10.1007/s00428-018-02511-7. Epub 2019 Jan 4.
Link
2179. Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.
Park CR1,2,3, Jo JH1,4,3, Song MG1,5, Park JY1,2, Kim YH1,6, Youn H1,3,7,8, Paek SH3,9,10, Chung JK1,2,3,7,11, Jeong JM1,2,3,12, Lee YS1,12, Kang KW1,2,3,12.
Theranostics. 2019 Oct 11;9(24):7447-7457. doi: 10.7150/thno.34883. eCollection 2019.
Link
2178. Versatile and Finely Tuned Albumin Nanoplatform based on Click Chemistry.
Park JY1,2, Song MG1,3, Kim WH4, Kim KW1, Lodhi NA1,5, Choi JY6, Kim YJ1,7,8, Kim JY9, Chung H10, Oh C6, Lee YS1,7, Kang KW1,7,8, Im HJ6, Seok SH10, Lee DS1,6, Kim EE1, Jeong JM1,7,8.
Theranostics. 2019 May 18;9(12):3398-3409. doi: 10.7150/thno.33143. eCollection 2019.
Link
2177. Combinatory low methylation statuses of SAT-α and L1 are associated with shortened survival time in patients with advanced gastric cancer.
Kim Y1,2, Wen X1,2, Jeong S2, Cho NY2, Kim WH1, Kang GH3,4.
Gastric Cancer. 2019 Jan;22(1):37-47. doi: 10.1007/s10120-018-0852-8. Epub 2018 Jun 20.
Link
2176. Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression.
Jang BG1, Kim HS1, Chang WY2, Bae JM3, Kim WH4, Kang GH5.
Am J Pathol. 2018 Oct;188(10):2236-2250. doi: 10.1016/j.ajpath.2018.06.012. Epub 2018 Jul 21.
Link